North American Society for the Study of Celiac Disease (EIN 454493481) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2011

Legal Domicile

Principal Officer

MARTIN E ROTH

Phone

6305227886

Tax Period

2019-01-01 to 2019-12-31

North American Society for the Study of Celiac Disease, founded in 2011, is a small nonprofit in the Diseases & Disorders sector that reported $189K in total revenue in fiscal year 2019. Revenue surged 1022% from the prior year, signaling strong growth momentum. Expenses of $174K left a modest 8% surplus.

Mission

Foster research and excellence in clinical care for celiac disease

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2019)

Revenue Breakdown

Contributions & Grants $189,046

Program Service Revenue $0

Investment Income $0

Other Revenue $0

TOTAL REVENUE $189,046

Expense Breakdown

Grants Paid $118,750

Salaries & Benefits $0

Fundraising Expenses $0

Program Expenses $174,034

Other Expenses $55,284

TOTAL EXPENSES $174,034

Year-over-Year Comparison

	2019	2018	Change
Revenue	$189,046	$16,856	+10.2%
Expenses	$174,034	$69,880	+1.5%
Net Income	$15,012	$-53,024	-1.3%

Key Indicators

✗ Grants to Organizations ✓ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

N/A

Independent Members

N/A

Employees

N/A

Volunteers

N/A

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
ELENA VERDU	Past President	2.000	Officer	$0	$0	$0
CIARAN KELLY	President	5.000	Officer	$0	$0	$0
MARTIN E ROTH	Executive Director	5.000	Officer	$0	$0	$0
BENJAMIN LEBWOHL	President Elect	2.000	Officer	$0	$0	$0
ALESSIO FASANO	Secretary	2.000	Officer	$0	$0	$0
DAWN ADAMS	Treasurer	2.000	Officer	$0	$0	$0
JULIO BAI	Councilor	2.000	Officer	$0	$0	$0
SHEILA CROWE	Councilor	2.000	Officer	$0	$0	$0
JOCELYN SILVESTER	Councilor	2.000	Officer	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2019	$189,046	$174,034	$136,481	$15,012

North American Society for the Study of Celiac Disease